beta
Trial Radar AI
I can help you find nearby clinical trials and understand health conditions and treatments.
36 Results
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Keywords
Hypoglycemia, Type 2 Diabetes
×
 
Intervention
GLP-1
×
 
Study Title
Status
GLP-1 and Hypoglycemia NCT01858896
Active, not recruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
Recruiting
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D) NCT05220917
Active, not recruiting
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery NCT00992901
Recruiting
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes NCT06825182
Recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents NCT07307235
Not yet recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
Comparative Effectiveness of Empagliflozin in the US NCT03363464
Active, not recruiting
Semaglutide Treatment in Type 1 Diabetes (OBES1TY) NCT06909006
Not yet recruiting
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. (EPHIC-DIA2) NCT06851962
Active, not recruiting
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control (MESSAGE) NCT07244003
Recruiting
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes (SEMPA) NCT06894784
Recruiting
CGM Use in Adults With Type 2 Diabetes on Basal Insulin NCT05944432
Active, not recruiting
iGlarLixi CGM Study in Chinese T2D Individuals After OADs (China Soli-CGM) NCT06671587
Recruiting
Semaglutide for the Treatment of Glucose Intolerance in Women with Prior Gestational Diabetes (SERENA) NCT05569772
Recruiting
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes NCT05313529
Active, not recruiting
The Postprandial Hypo-Avoid Study NCT07427251
Not yet recruiting
Effects on Remission of Type 2 Diabetes Mellitus Following Gastric Bypass Alone vs Gastric Bypass Combined With Truncal Vagotomy (VagusSx) NCT07278115
Not yet recruiting
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes (GLUREDIA) NCT06770621
Recruiting
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity (TZP-T1D) NCT06180616
Not yet recruiting
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus NCT07193459
Recruiting
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes (TIRTLE2) NCT06820281
Not yet recruiting
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus NCT07082114
Recruiting
Triple Therapy in T1DM NCT03899402
Active, not recruiting
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY) NCT05433584
Active, not recruiting
Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients NCT03987308
Recruiting
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar (TZP) NCT07284511
Not yet recruiting
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD) NCT03087032
Recruiting
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms NCT07073053
Not yet recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor NCT06221969
Active, not recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (REIMAGINE 5) NCT06534411
Active, not recruiting
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes (SOTA) NCT05696366
Recruiting
Tirzepatide Use in People With Obesity and Type 1 Diabetes NCT07096908
Not yet recruiting
Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes (T1Temp) NCT07491133
Not yet recruiting
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes NCT06762314
Recruiting
Human Models of Selective Insulin Resistance: Pancreatic Clamp NCT06558422
Not yet recruiting